UNSPSC 85816227: Introduction of high-dose interleukin-2 into peripheral vein, open approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of high-dose interleukin-2 into peripheral vein, open approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E03002

UNSPSC 85816227 Introduction of high-dose interleukin-2 into peripheral vein, open approach is a Commodity code representing a specific clinical procedure. State and local government procurement activity under this code shows little relevant recent activity; the opportunities tagged to it span virtual urgent care services, occupational health examinations, medical director oversight, cancer registry support, emergency medical services revenue billing, and a range of behavioral health and specialty medical services wholly unrelated to interleukin-2 administration or oncology immunotherapy infusion protocols. The mismatch between the code's clinical specificity and the actual procurements tagged to it suggests either systematic misclassification in source systems or that this particular UNSPSC commodity code does not reflect current state and local health service procurement patterns.

The recent opportunities in the dataset show that state and local issuing bodies—chiefly health departments, county behavioral health services, public health authorities, and hospital systems—are actively soliciting medical and behavioral health services across prevention, treatment, crisis response, and recovery domains. Nevada Health Authority, Ventura County, Santa Clara County Health System, Colorado Department of Human Services, Sedgwick County and the City of Wichita, and others are posting RFPs for PACE operations, crisis stabilization units, opioid use disorder treatment and recovery, emergency medical direction, occupational health screening, travel nurse staffing, and integrated behavioral health platforms. Geographic activity concentrates in California, Colorado, Kansas, Florida, Nevada, and Texas. None of these solicitations involve immunotherapy administration or related oncology services under the nominated code, indicating the code assignment is functionally orphaned from current state and local market activity.